Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 7:13:e18661.
doi: 10.7717/peerj.18661. eCollection 2025.

Deregulation mechanisms and therapeutic opportunities of p53-responsive microRNAs in diffuse large B-cell lymphoma

Elena N Voropaeva  1   2 , Yuriy L Orlov  3   4 , Anastasia B Loginova  2 , Olga B Seregina  2 , Vladimir N Maksimov  1   2 , Tatiana I Pospelova  2
Affiliations
Review

Deregulation mechanisms and therapeutic opportunities of p53-responsive microRNAs in diffuse large B-cell lymphoma

Elena N Voropaeva et al. PeerJ. .

Abstract

Here, we have discussed the molecular mechanisms of p53-responsive microRNAs dysregulation in response to genotoxic stress in diffuse large B-cell lymphoma (DLBCL) patients. The role of micro ribonucleic acids (microRNAs) in p53-signaling cellular stress has been studied. MicroRNAs are the small non-coding RNAs, which regulate genes expression at post-transcriptional level. Many of them play a crucial role in carcinogenesis and may act as oncogenes or suppressor of tumor growth. The understanding of the effect of p53-responsive microRNA dysregulation on oncogenesis achieved in recent decades opens wide opportunities for the diagnosis, prediction and of microRNA-based cancer therapy. Development of new bioinformatics tools and databases for microRNA supports DLBCL research. We overview the studies on the role of miRNAs in regulating gene expression associated with tumorigenesis processes, with particular emphasis on their role as tumor growth-suppressing factors. The starting point is a brief description of the classical microRNA biogenesis pathway and the role of p53 in regulating the expression of these molecules. We analyze various molecular mechanisms leading to this dysregulation, including mutations in the TP53 gene, DNA methylation, changes in host-genes expression or microRNA gene copy number, mutations in microRNA and microRNA biogenesis genes.

Keywords: Diffuse Large B-cell Lymphoma (DLBCL); Gene expression; microRNA regulation; microRNA-based cancer therapy; p53 response elements.

PubMed Disclaimer

Conflict of interest statement

Yuriy L. Orlov is an Academic Editor for PeerJ.

Figures

Figure 1
Figure 1. Somatic mutations in the TP53 gene in DLBCL.
(A) Distribution and characteristics of mutations in the TP53 gene in DLBCL according to the results of next generation sequencing (NGS) analysis of 1,295 samples presented in the cBioPortal for Cancer Genomics database (Gao et al., 2013); (B) impaired maturation of pri-miRNA to pre-miRNA in the case of mutations in codons 135, 175, 248 and 273, which are mutation hotspots in the TP53 gene.
Figure 2
Figure 2. Disturbance of genome copy number in the loci of p53-responsive microRNA genes.
(A) The frequency of detected chromosomal abnormalities (monosomies and deletions of microRNA gene loci) according to a classic cytogenetic study of 1,612 DLBCL samples with cytogenetic defects presented in the Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer (Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer, 2024) (B) Cases with decrease in genome copy number in the loci of p53-responsive microRNA genes (rose color) presented in the cBioPortal for Cancer Genomics database (Gao et al., 2013).
Figure 3
Figure 3. Spectrum and frequency of detected aberrations in microRNA biogenesis genes according to the analysis of 1295 DLBCL samples presented in the cBioPortal for Cancer Genomics database (Gao et al., 2013).
See this image and copyright information in PMC

References

    1. Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T. Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Science. 2007;98(12):1914–1920. doi: 10.1111/j.1349-7006.2007.00618.x. - DOI - PMC - PubMed
    1. Annese T, Tamma R, De Giorgis M, Ribatti D. microRNAs biogenesis, functions and role in tumor angiogenesis. Frontiers in Oncology. 2020;10:581007. doi: 10.3389/fonc.2020.581007. - DOI - PMC - PubMed
    1. Ashrafizadeh M, Zarrabi A, Orouei S, Kiavash H, Hakimi A, Amirhossein Z, Daneshi S, Samarghandian S, Baradaran B, Najafi M. MicroRNA-mediated autophagy regulation in cancer therapy: the role in chemoresistance/chemosensitivity. European Journal of Pharmacology. 2021;892:173660. doi: 10.1016/j.ejphar.2020.173660. - DOI - PubMed
    1. Asmar F, Hother C, Kulosman G, Treppendahl MB, Nielsen HM, Ralfkiaer U, Pedersen A, Møller MB, Ralfkiaer E, De Nully Brown P, Grønbæk K. Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: another double hit lymphoma with very poor outcome? Oncotarget. 2014;5(7):1912–1925. doi: 10.18632/oncotarget.1877. - DOI - PMC - PubMed
    1. Aya-Bonilla C, Green MR, Camilleri E, Benton M, Keane C, Marlton P, Lea R, Gandhi MK, Griffiths LR. High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to Non-Hodgkin’s lymphoma. Genes Chromosomes Cancer. 2013;52(5):467–479. doi: 10.1002/gcc.22044. - DOI - PubMed

MeSH terms

LinkOut - more resources